-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Gettex System der Börse MünchenSymbol ZEG-
AstraZenecaBörse London Stock ExchangeISIN GB0009895292 WKN: 886455
-
AstraZeneca PLCBörse London Stock ExchangeISIN US046353AX64
-
AstraZeneca PLCBörse London Stock Exchange
-
ASTRAZENECA PLCBörse Börse StuttgartISIN US046353AU26Symbol ZEG
-
AstraZenecaBörse Xetra FrankfurtISIN US046353AQ14Symbol ZEG
-
ASTRAZENECA PLCBörse Gettex System der Börse MünchenSymbol ZEG
-
ASTRAZENECA PLCBörse Tradegate System der Deutsche Börse AG (60%)Symbol ZEG
-
ASTRAZENECA PLCBörse Quotrix System der Börse DüsseldorfSymbol ZEG
-
ASTRAZENECA PLCBörse Börse HamburgSymbol ZEG
-
ASTRAZENECA PLCBörse Börse DüsseldorfSymbol ZEG
-
AstraZeneca PLCBörse Xetra FrankfurtISIN US046353AR96
-
AstraZenecaBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"ISIN GB0009895292 WKN: 886455Symbol AZN
-
AstraZeneca PLCBörse Nasdaq
-
ISIN US046353AN82Symbol ZEG
-
ISIN US046353AS79Symbol ZEG
-
Symbol ZEG
-
AstraZeneca PLCBörse OMXSISIN US046353AZ13
-
Symbol AZN.LN
-
ISIN US046353AG32
-
AstraZeneca PLCBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US0463531089
-
EUR
-
AstraZeneca PLCBörse Freiverkehr OTC
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
137.591.537.664 oder 121.186.000.000 oder 129.298.078.520
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
70.600 oder 83.500 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
64.72 oder 73.9
Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien beschäftigt 77.050 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
734 News & Informationen zur AstraZeneca Aktie
French health regulator recommends compulsory COVID-19 shots for health workers By Reuters
French health regulator recommends compulsory COVID-19 shots for health workers
Moderna : Saudi Arabia approves Moderna's COVID vaccine -state news agency
Saudi Arabia's Food and Drug
Authority on Friday approved Moderna Inc's COVID-19 vaccine
for use in the kingdom, the state news agency
said.
The authority added that after this… | July 9, 2021
EU finds potential link between heart inflammation and mRNA COVID shots By Reuters
EU finds potential link between heart inflammation and mRNA COVID shots
Countries using Chinese, Astra shots increasingly eye boosters
THEY’RE the main source of Covid-19 vaccines for much of the developing world, but concerns over the protection level provided by Chinese developers and AstraZeneca Plc., particularly against the virulent new delta strain, has some countries looking to provide extra doses. Though definitive evidence is yet to emerge validating the…
COVID-19 Treatment Clinical Landscape Research Report 2021: Pandemic Perspectives – US FDA Wastes No Time In COVID-19 Emergency Use Authorization Reviews
DUBLIN, July 9, 2021 /PRNewswire/ — The
F-star (FSTX), AstraZeneca Team Up for Novel STING Inhibitors
F-star partners with AstraZeneca for its novel STING inhibitor compounds. Resultantly, F-star's shares rise 9.1%.
U.S. Covid-19 hospitalizations rise as Delta Variant spreads
Daily admissions rose 6.8% after long decline, while outbreaks among unvaccinated pushed up new cases
The Smartest Stocks to Buy With $200 Right Now
You don't need to start with a pile of cash to build wealth on Wall Street.
3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season (Revised)
Stocks Analysis by Zacks Investment Research covering: Pfizer Inc, Alexion Pharmaceuticals Inc, AstraZeneca PLC ADR, AbbVie Inc. Read Zacks Investment Research's latest article on Investing.com
Sydney to face prolonged COVID-19 lockdown amid record 2021 cases By Reuters
Sydney to face prolonged COVID-19 lockdown amid record 2021 cases
Alexion acquisition by Astrazeneca closing in : stocks
I was typing this post as a question, but since I have now solved the question while I had almost finished writing the post, I will share it anyway …
Africa suffers worst surge in Covid cases as delta variant spurs third wave of pandemic
Covid cases in Africa are doubling every 18 days as the highly contagious delta variant rips through the continent.
£312m-plus haul for F-star from AstraZeneca cancer deal
In an all-Cambridge deal, F-star Therapeutics has lined up a huge payback from a licensing agreement with AstraZeneca. AstraZeneca will receive global rights to research, develop and commercialise next generation Stimulator of Interferon Genes (STING) inhibitor compounds from F-star. F-star is now eligible to receive upfront and near-term payments of up to $12 million. It will
Dow Plunges 500 Points As Delta Variant Fears Rattle Markets
The early selloff wiped out two weeks of stock-market gains.
F-star Therapeutics rises on agreement with AstraZeneca for STING inhibitors (NASDAQ:AZN)
F-star Therapeutics (FSTX) hasadded ~14.3%in the pre-marketafter announcing a licensingagreement with AstraZeneca (AZN) for next-generation Stimulator of Interferon Genes…
F-star Therapeutics Enters Into Exclusive Licensing Agreement With AstraZeneca For Novel STING Inhibitors
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. FSTX (“F-star” or the “Company”), a
Surging death toll fails to convince vaccine-wary South Africans
One of the world’s fastest pace of deaths from Covid-19 infections hasn’t been able to trounce widespread hesitancy over vaccines in South Africa.
Can Novavax Rise To The Manufacturing Challenge?
Novavax published results of its U.S. phase 3 trials for its Covid-19 vaccine in mid-June, noting that the shot was over 90% effective overall and 100% effective against moderate and severe disease, roughly in line with Covid vaccine leaders such as Pfizer and Moderna. Although the shot is likely…
Delta variant already dominant in U.S., CDC estimates show By Reuters
Delta variant already dominant in U.S., CDC estimates show
Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…
25 Highest Asthma Rates in the US by City
In this article we will take a look at the 25 highest Asthma Rates in the US by City. You can skip our detailed analysis of these cities and the problem…
Sydney extends lockdown as Delta outbreak spreads
A two-week lockdown of Sydney will be extended for at least another seven days as authorities race to stamp out an outbreak of the Delta variant that’s grown to more than 350 cases since mid-June and has spread to an aged-care facility. Current stay-at-home orders—except for exercise, essential shopping and…
EUROPEAN MIDDAY BRIEFING: Stocks Rise as Investors Shake Off Wall Street Losses
MARKET WRAPS Stocks: European stocks edged higher on Wednesday, shaking off losses on Wall Street triggered in part by softer-than-expected economic data. Resource stocks were leading the…
NVIDIA Launches UK’s Most Powerful Supercomputer, for
One of World’s Fastest AI Supercomputers to Enable UK Researchers in Digital Biology, Genomics, Quantum Computing and AI; Five Launch Partners Kicking Off…
AstraZeneca (AZN) Gets EC's Clearance for Alexion Acquisition
AstraZeneca (AZN) obtains European Commission's permission for the acquisition of Alexion. The deal is expected to close in the third quarter of 2021.
Metro cities halt first dose Covid jab as supply runs out
Several cities in the Philippine capital region have halted their first-dose vaccination programs as supply from the national government runs out. Makati City, home to the nation’s main financial district, said the scheduled inoculation of frontline workers receiving the Covid-19 vaccine for the first time won’t push through on Tuesday.…
AstraZeneca : receives clearance from the European Commission for the proposed acquisition of Alexion (Form 6-K)
AstraZeneca receives clearance from the European Commission for the proposed acquisition of Alexion
AstraZeneca's proposed acquisition of Alexion Pharmaceuticals, Inc. has… | July 6, 2021
Morning Briefing – International
European business leaders want a stronger hand with China, not decoupling
Executives from top European companies say EU calls for ‘strategic autonomy’ risk protectionism
Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research
– Increase in consumer preference from synthetic to bio-based ingredients and development in biotechnology fuel the growth of the global biotech i…
Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research
PORTLAND, Ore., July 5, 2021 /PRNewswire/ — Allied Market Research published a report, titled, 'Biotech Ingredients Market by Type (Active Pharma…
Wallenberg warns against using Covid as excuse for protectionism
Swedish industrialist says that EU politicians risk creating barriers to global trade
Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses
Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses – government official
Why Coming in Second Could Be Great News for Pfizer and Moderna
And it could mean more bad news for AstraZeneca.
UAE Approves Use of Moderna Coronavirus Vaccine: Gulf News
(Bloomberg) —
The United Arab Emirates, which overtook Seychelles to become the world’s most vaccinated nation, approved the use of coronavirus vaccine produced by Moderna Inc., Dubai-based Gulf News reported.
This is the world's most vaccinated nation. But Covid cases remain high
The Persian Gulf nation has so far administered 15.5 million doses, enough to cover 72.1% of its mostly expatriate population of 10 million based on a two-dose regimen
These COVID Therapies Appear to Be the Best and Worst at Treating New Variants
Here's how several leading COVID-19 antibody therapies compare based on pre-clinical testing.
India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
Phase-III trials of a vaccine made by India’s Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm said…
AstraZeneca : India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
Phase-III trials of a vaccine made by
India's Bharat Biotech showed it was 93.4% effective against
severe symptomatic COVID-19, the firm said… | July 3, 2021
Argentina opens door to U.S. vaccine donations with legal tweak By Reuters
Argentina opens door to U.S. vaccine donations with legal tweak